Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

2

Nonsurgical Management of Fulmninant Hepatic Failure - Hepatocyte transplantation and bioartificial liver -

Byung Ho Kim

Clin Mol Hepatol. 1996;2(2):116-128.

View: 2638 Download: 15

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 2166 Download: 12

3

Hepatitis B and C Virus in Hepatocellular Carcinoma

Young Soo Kim, Kwang Jae Lee, Young Soo Moon, Ki Baek Hahm, Jin Hong Kim, Sung Won Cho, Sang In Lee, Chan Sup Shim*

Clin Mol Hepatol. 1996;2(1):61-67. Published online January 1, 2000

View: 9089 Download: 20

Evaluation of Oral Thymomodulin Effect on the Patients with Chronic Viral Hepatitis B

Chul Hun Chung , Soong Hwan Lee , Yong Hyeon Jo , Yeon Soo kim , Seung Woo Nam , Oh Young Lee , Dong Soo Ha , Joo Hyun Sohn , Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):47-53.

View: 3285 Download: 40

Comparison of the Incidence of Hepatocellular Carcinoma in HBV - and HCV - associated Liver Cirrhosis ; A Prospective Study

Hyo Suk lee , Jun Haeng Lee , Moon Suk Choi , Chung Yong kim

Clin Mol Hepatol. 1996;2(1):21-28.

View: 2368 Download: 14

Reply to Correspondence

Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”

Pin-Nan Cheng, Ming-Lung Yu

Received April 5, 2024 Accepted April 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0228 [Epub ahead of print]

View: 537 Download: 24

Reply to correspondence

Reply to correspondence regarding “Evaluation of the histological scoring systems for autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”

Atsumasa Komori

Received April 9, 2024 Accepted April 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0242 [Epub ahead of print]

View: 593 Download: 16

Editorial

MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma

Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi

Received May 18, 2024 Accepted May 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0372 [Accepted]

View: 423 Download: 28

Original Article

Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC

Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du

Received January 20, 2024 Accepted May 28, 2024

DOI: https://doi.org/10.3350/cmh.2024.0058 [Accepted]

View: 503 Download: 77

Editorial

Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV

Cho-Rong Lee, Sung-Gyoo Park

Received June 20, 2024 Accepted July 3, 2024

DOI: https://doi.org/10.3350/cmh.2024.0465 [Accepted]

View: 176 Download: 31

Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is tenofovir better than entecavir?

Yewan Park, Dong Hyun Sinn

Received July 4, 2024 Accepted July 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0519 [Accepted]

View: 138 Download: 21

Reply to Correspondence

Reply to correspondence regarding “Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV”

Cho-Rong Lee, Sung-Gyoo Park

Received July 16, 2024 Accepted July 17, 2024

DOI: https://doi.org/10.3350/cmh.2024.0572 [Accepted]

View: 11 Download: 2

Prev 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

14.0
First decision

09 Days

Publication after acceptance

03 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5417	MAFLD: How is it different from NAFLD?
Viewed By 5223	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5105	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4737	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 1247

TOTAL : 1932350